Yahoo
Toronto - Delayed Quote CAD

Custom Health Holdings Inc. (CHLT.TO)

6.00 0.00 (0.00%)
At close: November 6 at 3:59:59 PM EST
Chart Range Bar
Loading chart for CHLT.TO
  • Previous Close 6.00
  • Open 5.99
  • Bid 2.00 x --
  • Ask 6.00 x --
  • Day's Range 5.90 - 6.00
  • 52 Week Range 5.25 - 11.00
  • Volume 10,300
  • Avg. Volume 7,152
  • Market Cap (intraday) 149.099M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.05
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 12.00
  • Moby Rating Neutral

Custom Health Holdings Inc., an AI-enabled healthcare technology company that operates an infrastructure platform designed to ensure medication therapy works as intended. The company connects in-home technology, pharmacy, and pharmacist-led clinicians to create continuous visibility into a patient's therapy. Its AdhereNet platform operates an integrated pharmacy network across Canada and the U.S. supporting medication delivery, continuous monitoring, and clinical action to enable earlier engagement and support improved outcomes. The company serves payors, health systems, physician practices, community pharmacies, and primary care providers. Custom Health Holdings Inc. was formerly known as Queue Ventures Ltd. and changed its name to Custom Health Holdings Inc. in June 2026. The company was founded in 2021 and is headquartered in Brentwood, Tennessee.

customhealth.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

CHLT.TO
45.45%
S&P/TSX Composite index (^GSPTSE)
12.31%

1-Year Return

CHLT.TO
45.45%
S&P/TSX Composite index (^GSPTSE)
18.89%

3-Year Return

CHLT.TO
45.45%
S&P/TSX Composite index (^GSPTSE)
80.53%

5-Year Return

CHLT.TO
45.45%
S&P/TSX Composite index (^GSPTSE)
66.80%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 7.39M
Earnings --
Profit Margin 0.00%

Q2

FY26

0
2M
4M
6M
0.0%

Analyst Insights

View More

Analyst Price Targets

12.00
12.00 Average
6.00 Current
12.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -273.85%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    21.59M

  • Net Income Avi to Common (ttm)

    -59.12M

  • Diluted EPS (ttm)

    -0.05

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.09M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More
Mobilize your Website
View Site in Mobile | Classic
Share by: